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Introduction
While the molecular genetic basis of over 3000 Mendelian disorders has been determined, much less progress has been made in understanding the mechanisms through which the underlying genetic variants initiate Mendelian disease phenotypes.
However, in Mendelian forms of salt-dependent hypertension in humans, it is widely believed that genetic research has successfully led to identification of the primary pathophysiologic mechanism by which genetic variants enable salt (NaCl) to initiate the increased blood pressure which characterizes these disorders. The primary mechanistic abnormality that enables initiation of the salt-induced hypertension in these
Mendelian disorders is of considerable interest irrespective of whatever mechanisms may serve to sustain or exacerbate the hypertension.
Causal mutations imparting large effects on blood pressure have been reliably identified in more than a half dozen Mendelian disorders associated with salt (NaCl)-dependent hypertension (Table 1) . [1] [2] [3] [4] Prevailing theory holds that identification of these molecular genetic defects has clarified the abnormal physiologic mechanism that mediates initiation of such Mendelian forms of salt-dependent hypertension. 2, 3 Specifically, based on the coupling of results of the molecular genetic studies with the results of classic physiologic studies by Guyton and others, 5, 6 it is said that "a final common pathway" exists which mediates the initiation of all Mendelian forms of saltdependent hypertension.
2, 3
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In this critical review, we examine the scientific evidence that is counter to the prevailing theory of "a final common pathway" proposed to account for initiation of all known Mendelian forms of salt (NaCl)-dependent hypertension in humans. 2, 3 One of the key questions we raise and that has not been considered in previous reviews of Mendelian forms of salt-dependent hypertension is: How did this theory on the initiation of all Mendelian forms of salt-dependent hypertension come to prevail even though the hemodynamic mechanism described in the theory's "final common pathway"
has not been shown to mediate initiation of Mendelian forms of salt-dependent hypertension in humans or in animals? In addition to questioning whether the prevailing theory's "final common pathway" accounts for the initiation of all Mendelian forms of salt-dependent hypertension, we present a different pathway through which the genetic alterations may often mediate initiation of hypertension in these disorders.
The Prevailing Theory on How Mendelian Gene Defects Enable Salt To Initiate Hypertension
The prevailing theory holds that in all known Mendelian forms of salt-dependent hypertension in humans (Table 1) , a genetically determined increase in activity of the epithelial sodium channel (ENaC) in the aldosterone sensitive distal nephron and or the sodium-chloride cotransporter (NCC) in the distal convoluted tubule is the primary mechanistic abnormality that enables salt to initiate the hypertension. 2, 3, 7, 8 If so, how do genetically induced increases in renal tubular activity of ENaC or NCC enable increases in salt intake to initiate hypertension? According to prevailing theory,
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4 mutations that increase renal tubular activity of ENaC or NCC cause abnormally large increases in renal reabsorption of salt that increase salt balance. 2, 3, 7, 8 It is said that "mutations that increase salt balance raise blood pressure" through mechanisms that "can be readily explained via an initial increase in plasma volume and cardiac output." 7 Specifically, an abnormal increase in renal tubular activity of ENaC or NCC is held to induce an abnormally large increase in the renal reabsorption of salt and water which in turn causes abnormally large increases in intravascular volume and cardiac output and therefore blood pressure. 2, 3, 7 The level of systemic vascular resistance is said to be "normal" during the initiation of hypertension induced by increased renal reabsorption of salt. 2 This sequence of events is depicted in Figure 1 and according to Lifton et al, constitutes a "final common pathway for the pathogenesis of hypertension" including all
Mendelian forms of salt-dependent hypertension. 2 Lifton et al. have noted that according to Ohm's law, arterial pressure is proportional to two factors: cardiac output and vascular resistance. 2 As shown in Figure   1 , the prevailing theory holds that an increase in renal salt reabsorption that expands plasma volume and transiently increases cardiac output is sufficient to account for the initiation of salt-dependent hypertension ( Figure 1 ). Since systemic vascular resistance is said to remain "normal" during the initiation of salt-induced increases in blood pressure, the theory holds that abnormalities in systemic vascular resistance are not involved in the initiation of salt-induced hypertension. The theory holds that vascular resistance becomes abnormal only later through a phenomenon termed 
5
"autoregulation" which reverses cardiac output towards normal and gives rise to the increased systemic vascular resistance that enables the hypertension to persist.
2, 9-12
Questioning the Prevailing Theory
The prevailing theory of the pathogenesis of Mendelian forms of salt-dependent hypertension is said to "fit nicely into our understanding of the physiology of blood pressure regulation, with the increased intravascular volume resulting in increased cardiac output due to increased stroke volume and a rise in blood pressure according to Ohm's law." 13 This theory, which could also be termed the "volume-loading/cardiac output" theory, rests on the untested assumption that genetic variants that increase renal tubular activity of ENaC or NCC hemodynamically account for the initiation of all
Mendelian forms of salt-dependent hypertension entirely by transiently causing abnormally high levels of cardiac output, , i.e., without also usually causing, or needing to be accompanied by, an abnormality in systemic vascular resistance ( Figure 1) . Accordingly, the current analysis focuses on several related questions: 1) Is, or is not, the hemodynamic initiation of all known Mendelian forms of salt-dependent hypertension in humans (Table 1) Na space) without developing hypertension. 15 In contrast, the presumed sodium retention and the increases in cardiac output that occur upon administration of aldosterone to dogs ingesting a high salt diet (~ 6 mmol/kg body weight/day), are associated with the onset of hypertension because the increases in cardiac output are not accompanied by normally expected, pressor offsetting decreases in systemic vascular resistance (Fig 2a,b ,c). 
9
In light of the observations of Krieger et al (Fig. 2,d ,e,f) 14 and DeClue et al 15 made during induction of salt retention in normal control dogs not given aldosterone, the studies of Montani et al (Fig. 2a, Nor did they include any experiments measuring the effects on cardiac output and vascular resistance of initiating aldosterone treatment in animals ingesting control diets containing low amounts of salt.
The foregoing observations are at odds with the prevailing theory that an abnormality in systemic vascular resistance is not involved in the initiation of hypertension in patients with Mendelian disorders characterized by abnormally high levels of aldosterone.
These observations are consistent with the possibility that an aldosterone-dependent abnormality in systemic vascular resistance, i.e., an aldosterone-dependent failure to normally vasodilate and reduce systemic vascular resistance during salt retention, is involved in the initiation of salt-dependent hypertension in Mendelian disorders characterized by abnormally high levels of aldosterone (Table 1) . and on 17α-hydroxylase deficiency by Waterman's laboratory 17, 18 Decreases in activity of either of these enzymes can give rise to increased circulating levels of mineralocorticoid hormones including deoxycorticosterone (DOC). There are no published studies of the serial changes in cardiac output and systemic vascular resistance that occur during initiation of salt-dependent increases in blood pressure in humans or animals with mutations in 11β-hydroxylase or 17α-hydroxylase. However, there are published studies of the systemic hemodynamic changes that occur during initiation of saltdependent increases in blood pressure in animals given DOC or metyrapone, a pharmacologic inhibitor of 11β-hydroxylase.
Obst et al reported that in mice, increases in systemic vascular resistance, not increases in cardiac output, mediate the initiation of hypertension induced by administration of deoxycorticosterone and salt (DOC-NaCl).
19
The finding that DOCNaCl treatment can induce hypertension even when increases in cardiac output are 
D e s t r o y a f t e r u s e .
11 prevented by beta-adrenergic blockade also indicates that increases in cardiac output are not always necessary for DOC-NaCl to initiate hypertension. 20 Similarly, Miller and colleagues reported that in some pigs, administration of deoxycortisterone together with ~ 5 mmol NaCl/kg body weight/day initiated hypertension by inducing increases in systemic vascular resistance without inducing increases in cardiac output.
21
In other pigs, the hypertension was initiated by increases in cardiac output that were not offset by decreases in systemic vascular resistance that might normally be expected to occur with salt retention.
In studies by Ferrario et al in dogs given deoxycorticosterone together with ~ 5 mmol NaCl/kg body weight/day, blood pressure increased with salt retention because systemic vascular resistance failed to sufficiently decrease and offset the pressor effect of a 20% increase in cardiac output.
22
Thus, Ferrario et al concluded that "alterations in vascular reactivity may play a role in the elevated pressure associated with DOC excess".
Unfortunately, none of these studies of DOCNaCl hypertension included a control group of normal salt-resistant animals studied before and during salt retention induced by administering a high salt diet alone, i.e., without DOC. Nevertheless, the results of all of these hemodynamic studies performed during induction of salt retention by administering DOC and NaCl, are consistent with the possibility that a mineralocorticoid-dependent abnormality in systemic vascular resistance, i.e., a failure to normally decrease systemic vascular resistance during salt retention, is often required for the combination of DOC and NaCl to initiate hypertension.
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The Mendelian form of salt-dependent hypertension caused by mutations that impair 11β-hydroxylase activity 1, 2 can be pharmacologically mimicked by giving salt and metyrapone, an inhibitor of 11β-hydroxylase. To investigate the mechanisms whereby inhibition of 11β-hydroxylase enables salt to induce hypertension in dogs, Bravo et al studied the hemodynamic effects induced by administering metyrapone with a low salt diet or with a high salt diet.
23
They found that in dogs given a low salt diet, metyrapone caused a 31% increase in cardiac output and a simultaneous decrease in total peripheral resistance such that blood pressure did not change.
However,
initiation of a high salt diet in these metyrapone treated dogs induced a "prompt" increase in blood pressure by causing an increase in total peripheral resistance without causing a further increase in cardiac output. In contrast, throughout initiation of salt loading in most salt-sensitive normotensive subjects, systemic vascular resistance is abnormal because it fails to decrease to a normal extent, i.e., to the same extent as that usually observed during salt loading in saltresistant normal controls.
29,30,33
Thus, the prevailing theory's "final common pathway"
for initiation of salt-dependent hypertension is inconsistent with the results of saltloading studies in salt-sensitive normotensive subjects versus salt-resistant normotensive controls.
The Importance of Salt Loading Studies in Normotensive Subjects
We are focusing on the results of salt loading studies in normotensive subjects rather than on those in hypertensive subjects because we are mainly interested in the It is also important to note that the salt loading study comparing salt-sensitive hypertensives versus salt-resistant hypertensives 34 did not include normal controls, i.e., normotensive, salt-resistant individuals. Because that study did not include normal controls, it did not determine whether the cardiac output and sodium balance responses to salt loading were normal or abnormal in the salt-sensitive hypertensives or in the salt-resistant hypertensives.
The normal response to initiation of salt loading, i.e., the usual response in saltresistant, normotensive controls, is a rapid and substantial decrease in systemic vascular resistance. 
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16 into account the fact that the normal response to initiation of salt loading is vasodilation and a decrease in systemic vascular resistance.
28-33
Thus, the prevailing theory overlooks the possibility that mutations causing Mendelian forms of salt-dependent hypertension enable salt to initiate the hypertension by causing an abnormality in systemic vascular resistance, specifically, a failure to normally vasodilate and decrease systemic vascular resistance in response to salt loading.
A "Vasodysfunction" Theory To Explain How Mendelian Gene Defects Enable Salt To Initiate Hypertension
We propose that for molecular genetic alterations to enable salt to initiate
Mendelian forms hypertension, they must often cause "vasodysfunction", i.e., a failure to normally vasodilate and decrease systemic vascular resistance in response to salt loading (increases in salt intake) (Figure 3) . In contrast to the prevailing, "volumeloading/cardiac output" theory which holds that systemic vascular resistance is normal during the initiation of salt-induced hypertension (Figure 1) , the "vasodysfunction" theory holds that a mutation-dependent abnormality in vascular resistance, i.e., the failure to normally vasodilate in response to salt loading, often mediates the ability of salt to initiate the hypertension in Mendelian disorders of hypertension. While the current analysis is focused on the hemodynamic events that initiate the salt-dependent increase in blood pressure, Figure 3 also depicts the changes in cardiac output and systemic vascular resistance believed to occur after the blood pressure has increased. The 
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Most normal salt-resistant humans can tolerate large increases in salt intake and salt retention without developing substantial increases in blood pressure because they vasodilate and decrease systemic vascular resistance in response to salt loading. 29, 30, 36 While extreme increases in salt intake, i.e., increases to levels more than 2 -3 fold greater than the upper limit of salt intake of most people in modern societies, may induce increases in blood pressure in most normal individuals
36
, non-extreme increases in salt intake to levels within the usual range of salt intake observed in modern societies do not 29, 30, 36, 37 . It should also be noted that in normotensive humans studied under tightly controlled dietary and environmental conditions for up to 200 days during which salt intake was varied between 6 grams/day to 12 grams/day, blood pressure showed no correlation with variations in sodium balance.
38
It is conceivable that under some unusual circumstances, e.g., when someone with a rare genetic defect that severely limits sodium excretory capacity increases their salt intake to an unusually high level (i.e., to a level well beyond the average amount of salt consumed in most populations), the increases in sodium retention and cardiac output might become sufficient to initiate hypertension. That is, the increases in salt retention and cardiac output might become so great that they induce increases blood Here we briefly discuss some of the mechanisms whereby mutations in
Mendelian disorders of salt-dependent hypertension could potentially impair the normal ability to decrease systemic vascular resistance in response to increases in salt intake. The gene defects underlying at least 6 of the 7 known Mendelian forms of saltdependent hypertension all appear to promote increased activity of epithelial sodium channels. It is well recognized that epithelial sodium channels or epithelial like sodium channels may be expressed not just in the renal tubule, but also in other tissues including the brain and the vasculature.
39-42
There is mounting evidence that alterations in activity of such epithelial sodium channels in the brain and vasculature can influence blood vessel function in ways that could influence vascular resistance and impair normal vasodilatory responses to changes in salt intake. For example, the work of Leenen's group has indicated that in Liddle syndrome, increases in ENaC activity in the brain may be necessary for initiation of salt-induced hypertension, perhaps by promoting increases in sympathetic outflow in response to salt-induced changes in cerebrospinal fluid sodium concentration, i.e., by promoting increases in neural activity that could interfere with normal vasodilatory responses to increases in salt intake. 
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20 activity in the endothelium can negatively modulate nitric oxide activity in resistance arteries, and they have also shown that blocking ENaC can enhance flow mediated vasodilation. 45 Thus, in concert with increases in cardiac output that can normally occur with salt loading, increases in ENaC activity in the brain and or vasculature could mediate initiation of salt-induced hypertension by impairing the ability of blood vessels to normally dilate and reduce vascular resistance in response to salt loading.
The prevailing theory on how salt initiates Mendelian forms of hypertension 2, 3 does not take into account the evidence that epithelial sodium channels are expressed in many cell types besides just the renal tubular epithelium.
39-42
The theory 2, 3 also does not take into account the possibility that during the initiation of Mendelian forms of salt-dependent hypertension characterized by increases in mineralocorticoid levels, the mineralocorticoids could be impairing normal vasodilatory responses to salt by affecting the activity of a variety of ion channels in the vasculature in addition to ENaC. It is now well recognized that mineralocorticoids and mineralocorticoid receptors have effects on several ion channels outside the renal tubule that can affect vascular function in ways that could contribute to the initiation of salt-dependent hypertension.
46
It is also conceivable that is some Mendelian disorders, the mutations disturb the distribution of salt in tissues such as the brain and or vasculature and this in turn affects vascular function in a manner that impairs the ability to normally vasodilate in response to salt.
Familial hyperkalemic hypertension (FHHt) is a group of Mendelian disorders in
which the prevailing theory holds that the causative mutations enable salt to initiate
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Are Genetically Induced Increases in Net Salt Retention and Cardiac Output Necessary for Mendelian Gene Defects to Enable Salt Loading to Initiate
Hypertension ?
In addition to holding that an abnormality in vascular resistance is often required for Mendelian gene defects to enable salt to initiate the hypertension, the "vasodysfunction" theory ( Figure 3 ) raises a related issue: For the gene defects to enable an increase in salt intake to initiate hypertension, is it necessary for the mutations to induce greater increases in net salt retention and cardiac output than would otherwise be induced by an increase in salt intake in the absence of the mutations? In humans and in animal models with mutations that underlie the Mendelian forms of salt-dependent hypertension shown in Table 1 , it has not been demonstrated that mutation-dependent increases in renal salt retention and cardiac output are necessary for the mutations to enable increases in salt intake to initiate the hypertension. That is, it has not been shown that mutation-induced increments in net salt retention and cardiac output beyond those induced by increasing salt intake in wild type, normal salt-resistant subjects, are necessary for the mutations to enable an increase in salt intake to initiate hypertension. Accordingly, the vasodysfunction theory (Figure 3 ) leaves open the possibility that mutation-dependent increases in renal tubular epithelial sodium transport which cause increases in salt retention and cardiac output, may not always be necessary for the mutations to enable increases in salt intake to initiate the hypertension. hypertension, yet the mutation did not reduce the amount of sodium excreted in the urine; throughout salt loading, the amount of sodium excreted by mutant animals was the same as that excreted by wild type, salt-resistant controls.
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The wild type, saltresistant controls tolerated the large salt load without developing increased blood pressure despite retaining apparently large amounts of sodium. Table 1) . The current analysis also raises questions about whether mutation-dependent increases in renal tubular activity of ENaC or NCC are even necessary to account for increased risk for salt-dependent hypertension in most patients with such mutations.
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We propose that for the genetic alterations underlying Mendelian forms of saltdependent hypertension to enable increases in salt intake to initiate the increased blood pressure, they must often cause "vasodysfunction", i.e., an inability to normally vasodilate and decrease systemic vascular resistance in response to increases in salt intake within dietary ranges typically observed in most modern societies. A subnormal ability to vasodilate in response to salt loading could be caused by mutation related disturbances originating in the vasculature itself or in sites outside the vasculature (e.g., brain or adrenal glands) that have the capacity to affect vascular function. and increases in cardiac output.
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In this pathway, salt-induced decreases in renal vascular resistance are held to : 1) contribute to the salt-induced decreases in systemic vascular resistance that hemodynamically prevent salt-induced increases in cardiac output from causing hypertension, and 2)
contribute to the achievement of salt balance by facilitating sodium excretion.
Note that while this pathway is focused on the initiation phase of salt-loading, it also depicts changes in cardiac output and systemic vascular resistance that transpire after the salt-induced increase in cardiac output and the salt-induced decrease in systemic vascular resistance have occurred. In salt resistant normotensive humans, it has been shown that after occurrence of the salt-induced increase in cardiac output and the salt-induced decrease in systemic vascular resistance, the level of cardiac output decreases back towards baseline while the level of systemic vascular resistance (Table 1) can enable non-extreme increases in dietary salt intake to initiate hypertension. Non-extreme increases in salt intake are defined as increases within the range of usual daily salt intake observed in modern societies. In this pathway, the genetic alterations enable increases in dietary salt intake to initiate hypertension by causing "vasodysfunction", i.e., an inability to normally vasodilate and normally decrease systemic vascular resistance in response to the increased salt intake. This is depicted in the figure as an inhibitory effect of the mutations on the arterial vasodilation response that is normally expected to occur with an increase in salt intake. Note that the mutation-dependent inability to normally decrease systemic vascular resistance (SVR) in response to salt includes an inability to normally decrease renal vascular resistance (RVR) in response to salt. During initiation of salt-induced hypertension, RVR may actually increase in salt-sensitive subjects.
In this pathway, a mutation-dependent inhibitory effect on salt output is labeled with question marks. This is because mutation-dependent inhibitory effects on urinary in normal people. Further, mutationdependent inhibitory effects on urinary excretion of salt have not been established to be necessary for the mutations to enable increases in salt intake to initiate hypertension in these disorders. Thus, in this pathway, increases in salt retention, cardiac output and blood pressure induced by increasing salt intake may not necessarily depend on mutation-induced increases in activity of ENaC or NCC in the renal tubular epithelium.
Moreover, even if mutation-induced alterations in renal tubular activity of ENaC or NCC do enhance the increases in salt retention and cardiac output normally induced by a high salt intake, the transient increases in cardiac output may often not be sufficient to initiate hypertension unless "vasodysfunction" is also present.
Note that with continuation of the high salt intake, salt balance (the state in which salt output matches salt intake) is eventually achieved and maintained. The saltinduced high blood pressure can promote salt output (natriuresis) and contribute to achievement of salt balance but it does not result in a level of "pressure-natriuresis" great enough to cause salt output to exceed salt intake and prevent high blood pressure from being sustained. This is because the extent of such "pressure-natriuresis" in saltsensitive individuals is constrained by the abnormal renal vascular resistance response to increased intake of salt. 
